Alan Brochstein is a Founding Partner at New Cannabis Ventures. He is an authority on investing in the rapidly evolving legal cannabis industry, focusing on cannabis business and regulation, as well as the emerging field of psychedelics. Alan has been featured in prominent publications such as New Cannabis Ventures and Seeking Alpha.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Alan Brochstein's coverage predominantly focuses on analyzing and citing data related to the cannabis industry, particularly in relation to investment analysis. He shows a keen interest in financial aspects such as stock performance, market trends, and sales figures within the cannabis sector.
Considering his strong focus on investment analysis and data citation, Alan would likely be most responsive to pitches that offer unique insights into the financial performance of specific companies within the cannabis industry or provide access to exclusive data relevant to this sector.
Given his geographic focus on Florida and the United States at large, pitches should ideally tie in local angles or regulatory developments with broader implications for the US cannabis market.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Summary Tilray Brands (TLRY) remains a Hold, with valuation near tangible book value and a mixed Q3 showing revenue growth but margin pressure.
New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA's monthly cannabis sales data for 15 states.
Michigan cannabis sales for March fell from a year ago as they increased sequentially by 8.9%. At $255.5 million, sales were down 7.8% from a year earlier:
FacebookTwitterLinkedIn You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. We no longer send these by email as we did in the past, but we post this and all of the newsletters on our website here.
Summary AdvisorShares Pure US Cannabis ETF remains a Strong Sell due to extreme concentration in three names and excessive volatility.
Statistics Canada released February retail sales for the country, with cannabis sales decreasing from the January levels, down 7.9% to C$440.5 million from the prior month. The sequential decrease was up 2.0% on a per-day basis more due to the fewer days than in the prior month. January, originally reported at C$466.1 million, was revised higher to C$478.2 million. The sales in February were up 7.9% from a year ago, down from the level last month at 9.4% and in May at 8.3% and 7.5% in June but better than the prior lowest annual growth rate since legalization commenced of -0.9% in September 2024 due to the BC strike. In 2024, total sales increased 4.5% to C$5.39 billion, and they were up 4.1% in 2025 to C$5.62 billion. So far in 2026, sales are up 8.6%.
Aurora Cannabis Inc. outlook: improving international revenue, margins, and net cash. Valuation suggests 64% upside to $5.58. Click for more on ACB stock.
Summary Verano Holdings is upgraded to Buy, reflecting improved industry outlook and compelling valuation versus MSO peers.
The Boston Beer Company, Inc. stock: valuation, earnings outlook, and risks after the pullback. Click for this updated look at SAM stock following its latest news.
Statistics Canada released March retail sales for the country, with cannabis sales increasing from the February levels, up 7.4% to C$471.4 million from the prior month.
